National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

C1inhibitor (human) (Cinryze® 500 Units powder and solvent for solution for injection)

Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE)

Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment

Rapid Review

Commenced Completed Outcome
22/10/2012 14/11/2012 Full pharmacoeconomic assessment not recommended